Context Flavokawains are secondary metabolites from the kava plant (Piper methysticum Forst. f., Piperaceae) that have anticancer properties and demonstrated oral efficacy in murine cancer models. However, flavokawains also have suspected roles in rare cases of kava-induced hepatotoxicity. Objective To compare the toxicity flavokawains A and B (FKA, FKB) and monitor the resulting transcriptional responses and cellular adaptation in the human hepatocyte cell line, HepG2. Materials and methods HepG2 were treated with 2–100 μM FKA or FKB for 24–48 h. Cellular viability was measured with calcein-AM and changes in signaling and gene expression were monitored by luciferase reporter assay, real-time PCR and Western blot of both total and nuclear protein extracts. To test for subsequent resistance to oxidative stress, cells were pre-treated with 50 μM FKA, 10 μM FKB or 10 μM sulforaphane (SFN) for 24 h, followed by 0.4–2.8 mM H2O2 for 48 h, and then viability was assessed. Results FKA (≤ 100 μM) was not toxic to HepG2, whereas FKB caused significant cell death (IC50 = 23.2 ± 0.8 μM). Both flavokawains activated Nrf2, increasing HMOX1 and GCLC expression and enhancing total glutathione levels over 2-fold (p < 0.05). FKA and FKB also activated HSF1, increasing HSPA1A and DNAJA4 expression. Also, flavokawain pretreatment mitigated cell death after a subsequent challenge with H2O2, with FKA being more effective than FKB, and similar to SFN. Conclusions Flavokawains promote an adaptive cellular response that protect hepatocytes against oxidative stress. We propose that FKA has potential as a chemopreventative or chemotherapeutic agent.
The transcription factor c-myc has an important role in the control of cell proliferation, differentiation and apoptosis. The dysregulation of c-myc activity is a feature of many cancers. Although it enhances proliferation, the overexpression of c-myc also sensitizes cells to a variety of pro-apoptotic stimuli. 4-hydroxynonenal (HNE) is a reactive lipid that is generated as a consequence of oxidative stress, and is found to be elevated in many solid lesions. HNE is known to promote apoptosis in various cancer cell types, including colorectal cancer cells. We therefore decided to investigate whether c-myc has a role in HNE-induced apoptosis in this setting. We began by investigating the effect of HNE on c-myc expression and function. Treatment of colorectal cancer cell lines RKO and HCT-116 with HNE caused a time- and concentration-dependent nuclear accumulation of c-myc protein. The increase in nuclear c-myc levels was not accompanied by an increase in either c-myc mRNA or total cellular levels, leading us to speculate that enhanced nuclear import or sequestration are involved. To evaluate whether c-myc activity was also increased in response to HNE, we used a luciferase reporter construct bearing a conserved c-myc binding element. These data reveal that in addition to causing its nuclear accumulation, HNE also enhances c-myc transcriptional activity. To examine the consequence of c-myc activation and explore its role in HNE-induced apoptosis, we silenced c-myc expression using 3 different siRNA sequences in both the RKO and HCT-116 cell lines. Silencing c-myc expression caused a significant attenuation of apoptosis in HNE-treated cells, as evidenced by a reduction in caspase 3 cleavage, PARP cleavage, and caspase 3 activity assays. To investigate the reason behind this effect, we examined known pathways for HNE-induced apoptosis. In accordance with published data, we find that HNE promotes apoptosis through the ASK1-JNK pathway, and that apoptosis can be blocked with an ASK1-specific inhibitor. Furthermore, our data show for the first time that silencing c-myc expression leads to a profound reduction in the phosphorylation and activity of JNK, which we propose explains the reduction in apoptosis in c-myc deficient cells. Since c-myc is a protein of interest and potential target for colorectal therapy, the consequence of its inhibition on cancer cell viability and cell death pathways is critical to understand. Together, our work reveals a novel pathway for c-myc mediated apoptosis and highlights its importance in HNE-treated cancer cells. Citation Format: Christina TK Wales, Rachel Gristock, Nadine So, Aaron T. Jacobs. c-Myc is critical for apoptosis in 4-hyroxynonenal-treated colorectal cancer cells. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1246. doi:10.1158/1538-7445.AM2015-1246
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.